2015
DOI: 10.1590/1414-431x20144142
|View full text |Cite
|
Sign up to set email alerts
|

Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus

Abstract: The production of oxygen free radicals in type 2 diabetes mellitus contributes to the development of complications, especially the cardiovascular-related ones. Peroxiredoxins (PRDXs) are antioxidant enzymes that combat oxidative stress. The aim of this study was to investigate the associations between the levels of PRDX isoforms (1, 2, 4, and 6) and cardiovascular risk factors in type 2 diabetes mellitus. Fifty-three patients with type 2 diabetes mellitus (28F/25M) and 25 healthy control subjects (7F/18M) were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 26 publications
1
16
0
Order By: Relevance
“…Inflammation often complicates diseases associated with oxidative stress like diabetes mellitus, so this enzyme acts as redox-dependent inflammatory mediator both in vivo and in vitro , modifying the redox status of cell surface receptors and enabling induction of inflammatory responses [26]. So, our findings of significant increased expression in both somatic and embryonic cells support the DOHaD concept and the existence of an interesting crosstalk between PRDX isoform 2 and long-term metabolic diseases and cardiovascular risks [27]. Moreover this antioxidant protection against oxidative stress, also suggest a novel therapeutic mechanism for treating metabolic disorders [71].…”
Section: Discussionsupporting
confidence: 52%
See 2 more Smart Citations
“…Inflammation often complicates diseases associated with oxidative stress like diabetes mellitus, so this enzyme acts as redox-dependent inflammatory mediator both in vivo and in vitro , modifying the redox status of cell surface receptors and enabling induction of inflammatory responses [26]. So, our findings of significant increased expression in both somatic and embryonic cells support the DOHaD concept and the existence of an interesting crosstalk between PRDX isoform 2 and long-term metabolic diseases and cardiovascular risks [27]. Moreover this antioxidant protection against oxidative stress, also suggest a novel therapeutic mechanism for treating metabolic disorders [71].…”
Section: Discussionsupporting
confidence: 52%
“…In particular the isoform 2, PRDX2, was described upregulated in diabetic patients versus healthy control subjects [27], and this is the reason why we considered this gene of interest. The expression was higher in treated cells of all the four cells lines analysed, with a similar increase of gene expression activity across the range analysed for both somatic (Figures 3I and 3R) and embryonic cells (Figure 4I).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, decreased mRNA levels of Prdx1 and Ucp-1 , two important players of the antioxidant defense, were detected in isolated rats with respect to animals reared in group. Prdx1 is a member of the peroxiredoxin family of antioxidant enzymes, reducing hydrogen peroxide and alkyl hydroperoxides ( He et al, 2015 ), involved in the maintenance of different physiological functions, as well as in the pathogenesis of several diseases, such as inflammation-mediated disorders, tumorigenesis ( El Eter and Al-Masri, 2015 ) and neurological illnesses ( Zhu et al, 2012 ). Interestingly, a decrease in Prdx1 has been also associated with the development of impaired metabolism-associated disorders, such as type 2 diabetes and cardiovascular diseases ( El Eter and Al-Masri, 2015 ).…”
Section: Discussionmentioning
confidence: 99%
“…have diminished capacity to handle oxidative stress. It is intriguing that serum of patients with T2D has higher levels of circulating PRDX4 than controls (34) although the cell source of the PRDX4 is not yet known (11; 35).…”
Section: Discussionmentioning
confidence: 99%